Retatrutide appears to be a new pharmaceutical in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By stimulating https://haleemancxy171043.theideasblog.com/36756001/tirzepatide-a-promising-new-treatment-for-obesity